Could drugs for mood disorders, pain and epilepsy cause psychiatric disorders later in life?

Oct 20, 2009

Young animals treated with commonly-prescribed drugs develop behavioral abnormalities in adulthood say researchers at Georgetown University Medical Center. The drugs tested include those used to treat epilepsy, mood disorders and pain.

GUMC neuroscientists and others have previously shown that neurons die after these drugs are administered to immature preclinical animal models. They say the regions of the brain where this drug-induced cell death takes place are important in the regulation of mood, cognition, and movement. In the research presented at the 39th annual meeting of the Society for Neuroscience, the scientists examined if behavioral function would be affected by the drugs.

Using behavioral tests to detect characteristics of and schizophrenia, the researchers found that when given to infant rats, the drugs caused behavioral abnormalities later in life. What's more, the abnormalities were not limited to the drugs known to cause .

"That is of particular concern because some of the drugs may predispose to later in life," says lead author Patrick Forcelli, a graduate student in the Interdisciplinary Program in Neuroscience at GUMC. "At the same time, our studies identify specific drugs that cause little or no long-term behavioral impairment." Forcelli says additional research will help physicians to better select drugs to treat epilepsy, mood disorders or pain in infants and pregnant women.

Source: Georgetown University Medical Center (news : web)

Explore further: Controlling brain waves to improve vision

add to favorites email to friend print save as pdf

Related Stories

Epilepsy drug may increase risk of autism in children

Dec 01, 2008

A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child's risk of developing autism. The preliminary research is published in the December 2, 2008, print issue ...

Fine-tuning treatments for depression

Oct 18, 2009

New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression.

Recommended for you

Controlling brain waves to improve vision

8 hours ago

Have you ever accidentally missed a red light or a stop sign? Or have you heard someone mention a visible event that you passed by but totally missed seeing?

Study suggests targeting B cells may help with MS

9 hours ago

A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced disease activity for people with multiple sclerosis (MS). The study is released today ...

Paying closer attention to attention

13 hours ago

Ellen's (not her real name) adoptive parents weren't surprised when the school counselor suggested that she might have attention deficit hyperactivity disorder (ADHD).

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.